Appointment strengthens the experience of RareCan

RareCan, a new company accelerating research into rare cancers, has appointed Dr Anita Cooper as Non-Executive Director. The appointment is said to strengthen the scientific and pharmaceutical experience of RareCan’s board in support of the company’s planned commercial growth.

With over 30 years’ global business experience, Cooper has worked across diverse functions, skill levels and geographies, including strategy development and implementation, risk management, operations and technology-enabled process transformation across the US, Latin America, Europe, India, Japan, South Korea, Taiwan and China. She is currently a Non-Executive Director for Simbec-Orion, a Clinical Research Organisation with specialist expertise in clinical pharmacology, oncology and rare diseases. Prior to this, she served as an Executive Officer and Senior Vice-President of Parexel, a US based, global pharmaceutical services company.

Piers Kotting, CEO of RareCan, commented: “We are thrilled to welcome Anita to the Board of RareCan. Anita’s wealth of industry experience will help us to accelerate rare cancer research by maximising the value of RareCan to both the global life sciences and pharmaceutical services industries.”

Cooper’s appointment follows the news that RareCan has been shortlisted for Start Up Entrepreneur of the Year at the 2021 Great British Entrepreneur Awards for the NorthEast region. The awards celebrate and champion the entrepreneurs behind brilliant businesses. Winners will be announced in September.

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free